Biomarker databases

Biomarker database There are several databases that are used to track biomarkers. The important thing to keep in mind is that the biomarker may be biological entity like a protein, lipid or DNA/RNA fragment but they can also be a group of cells – for example Tumor infiltrating cells or, physiological test, clinical outcome measure even an online test. The biomarker databases usually add a list of publications and some other resources such as usage in clinical trials or review by FDA. These database useful if the main purpose is to search through a list and sort out the important ones in an exploratory study. However, the critical test for any biomarker is to determine if it indeed follows the disease and/or the drug being developed to modify the disease. Here is a list of some of those Biomarker databases, with a very short review on each.

 

Public domain:

NCI has their own database that is cancer specific and has comprehensive information. https://edrn.nci.nih.gov/biomarkers#b_start=0

Online Mendelian Inheritance in Man (OMIM) for gene disorders: Not quite a biomarker database but possible to find immense amount of information quickly. http://www.omim.org/

Human Metabolome database: This is comprehensive and searchable if you are looking for a metabolite for a specific disease. http://www.hmdb.ca/

Disease related biomarkers from a publication that needs some understanding to fully utilize the resources. http://ibi.imim.es/biomarkers/

US EPA has a database that can be downloaded by anyone but has not been updated since 2004. https://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=85844

 

Disease specific:

To find specific disease type through an ontology use this portal http://medportal.bmicc.cn/ontologies/DOID

 

Or use this for details on human diseases: http://www.malacards.org/

Urinary protein biomarker. This is quite comprehensive and searchable and worth a look. http://59.108.16.249/biomarker/web/indexdb

Stroke biomarkers. Good classification of some areas within stroke and can lead to interesting areas to click to explore new biomarkers. http://stroke-biomarkers.com/

Alzhiemer’s research https://www.alzforum.org/alzbiomarker

 

 

Sampling of some Commercial ones:

Charles River have created an accessible database for some disorders that is great for exploring new areas. https://www.criver.com/resources/biomarker-database

BiomarkerBase by Amplion: They promise a lot but without the ability to test ride the database. https://www.biomarkerbase.com/

Global online biomarker database (Gobiom) by GVKBio claims to be the biggest one and some of their work goes through significant amounts of data to sort out characteristic of specific biomarkers. https://gobiomdb.com/login.jsp

 

 

This is not a comprehensive list and needs work to build up a database of databases.

Similar Posts

  • |

    Bile duct cancer

    Bile duct cancer or cholangiocarcinoma, (CCA) is a rare cancer with an incidence of ~3 cases per 100,000 with 10,000 new case diagnosed annually. It is about 10-20% of liver cancers. Interestingly, in Thailand, and some south east asian countries, the incidence is nearly 10 fold higher due to liver fluke infections (Opisthorchis viverrini and…

  • Acuity measurement

    How does a hospital measure the acuity of an illness? Acuity is defined loosely as the severity of an illness. The more severe an illness or malady is the more attention it deserves. For example, chest pain is critical and deserves attention vs. flu like symptoms do not deserve as much attention. A doctor in…

  • Autism and fever

    There have been studies, that show that in a significant proportion of Autistic patients the symptoms of Autism decreases when the patients have a fever, or are treated with an antibiotic – vancomycin. This effect has been known since about 1980 and (also reported on the web at Simons foundation too). When a fever ran…

  • |

    PROTAC databases

    PROTAC (Proteolysis targeting chimera) is fantastic technology that can degrade specific proteins. It uses a small molecule with a capability to bind the protein to be degraded and an active site that binds to E3 ubiquitin ligase. Using the PROTAC pulls the protein into ubiquitin based degradation pathways by ubiquitination of the protein and subsequent…

  • Biomarkers on your face

    Face recognition technology has come a long way. The technology now enables the specific association of the face with a name and thus confirmed identification. The technology of recognition is very complex and requires not only significant image processing of the face to identify features of interest but also then matching the features with those…

  • |

    Bisphenol A

    There is lot of information on BPA on wikipedia that talks about its use in plastics especially polycarbonates that are used in water bottle manufacturing. Polycarbonate bottles are transparent and can contain 90% BPA by mass It is not a plasticizer. The concern for its use comes from its effect as a weak xenoestrogen disrupting…